114 related articles for article (PubMed ID: 30947659)
1. MADD Expression in Lung Adenocarcinoma and its Impact on Proliferation and Apoptosis of Lung Adenocarcinoma Cells.
Ye B; Zhong F; Yu G; Lou H; Hu J
Comb Chem High Throughput Screen; 2019; 22(3):207-215. PubMed ID: 30947659
[TBL] [Abstract][Full Text] [Related]
2. [Expression of MADD in lung adenocarcinoma tissues and its effects on proliferation and apoptosis of lung adenocarcinoma A549 cells].
Wei YP; Wu JX; Guo YF; Sun GY; Zhang Q; Bi WX; Dong L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):354-7. PubMed ID: 22482404
[TBL] [Abstract][Full Text] [Related]
3. MADD promotes the survival of human lung adenocarcinoma cells by inhibiting apoptosis.
Bi W; Wei Y; Wu J; Sun G; Guo Y; Zhang Q; Dong L
Oncol Rep; 2013 Apr; 29(4):1533-9. PubMed ID: 23443411
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
Gao P; Wang Z; Hu Z; Jiao X; Yao Y
J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
[TBL] [Abstract][Full Text] [Related]
5. Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand.
Li LC; Jayarama S; Pilli T; Qian L; Pacini F; Prabhakar BS
Thyroid; 2013 Jan; 23(1):70-8. PubMed ID: 22998497
[TBL] [Abstract][Full Text] [Related]
6. MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.
Kurada BRVVSN; Li LC; Mulherkar N; Subramanian M; Prasad KV; Prabhakar BS
J Biol Chem; 2009 May; 284(20):13533-13541. PubMed ID: 19289468
[TBL] [Abstract][Full Text] [Related]
7. TRAIL suppresses human breast cancer cell migration via MADD/CXCR7.
Wang R; Li JC
Asian Pac J Cancer Prev; 2015; 16(7):2751-6. PubMed ID: 25854358
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
Wang LQ; Wong KY; Rosèn A; Chim CS
Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
[TBL] [Abstract][Full Text] [Related]
9. MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells.
Turner A; Li LC; Pilli T; Qian L; Wiley EL; Setty S; Christov K; Ganesh L; Maker AV; Li P; Kanteti P; Das Gupta TK; Prabhakar BS
PLoS One; 2013; 8(2):e56817. PubMed ID: 23457619
[TBL] [Abstract][Full Text] [Related]
10. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
Saini S; Sripada L; Tulla K; Qiao G; Kunda N; Maker AV; Prabhakar BS
Endocr Relat Cancer; 2019 Jun; 26(6):551-563. PubMed ID: 30999276
[TBL] [Abstract][Full Text] [Related]
11. IG20/MADD plays a critical role in glucose-induced insulin secretion.
Li LC; Wang Y; Carr R; Haddad CS; Li Z; Qian L; Oberholzer J; Maker AV; Wang Q; Prabhakar BS
Diabetes; 2014 May; 63(5):1612-23. PubMed ID: 24379354
[TBL] [Abstract][Full Text] [Related]
12. MADD is a downstream target of PTEN in triggering apoptosis.
Jayarama S; Li LC; Ganesh L; Mardi D; Kanteti P; Hay N; Li P; Prabhakar BS
J Cell Biochem; 2014 Feb; 115(2):261-70. PubMed ID: 24038283
[TBL] [Abstract][Full Text] [Related]
13. MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.
Mulherkar N; Ramaswamy M; Mordi DC; Prabhakar BS
Oncogene; 2006 Oct; 25(47):6252-61. PubMed ID: 16682944
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis.
Subramanian M; Pilli T; Bhattacharya P; Pacini F; Nikiforov YE; Kanteti PV; Prabhakar BS
J Clin Endocrinol Metab; 2009 Apr; 94(4):1467-71. PubMed ID: 19190106
[TBL] [Abstract][Full Text] [Related]
15. Trefoil factor 3 silencing can inhibit the proliferation and apoptosis of lung cancer cells.
Liu M; Xiao Y
J BUON; 2021; 26(5):1842-1849. PubMed ID: 34761591
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor alpha-induced apoptosis and activation of caspase-8 and -3.
Al-Zoubi AM; Efimova EV; Kaithamana S; Martinez O; El-Idrissi Mel-A; Dogan RE; Prabhakar BS
J Biol Chem; 2001 Dec; 276(50):47202-11. PubMed ID: 11577081
[TBL] [Abstract][Full Text] [Related]
17. Loss of MADD expression inhibits cellular growth and metastasis in anaplastic thyroid cancer.
Saini S; Sripada L; Tulla K; Kumar P; Yue F; Kunda N; Maker AV; Prabhakar BS
Cell Death Dis; 2019 Feb; 10(2):145. PubMed ID: 30760700
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA LINC00472 Inhibits Proliferation and Promotes Apoptosis of Lung Adenocarcinoma Cells via Regulating miR-24-3p/ DEDD.
Su C; Shi K; Cheng X; Han Y; Li Y; Yu D; Liu Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818790490. PubMed ID: 30175664
[TBL] [Abstract][Full Text] [Related]
19. MADD/DENN/Rab3GEP functions as a guanine nucleotide exchange factor for Rab27 during granule exocytosis of rat parotid acinar cells.
Imai A; Ishida M; Fukuda M; Nashida T; Shimomura H
Arch Biochem Biophys; 2013 Aug; 536(1):31-7. PubMed ID: 23702376
[TBL] [Abstract][Full Text] [Related]
20. FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells.
Xu N; Zhang X; Wang X; Ge HY; Wang XY; Garfield D; Yang P; Song YL; Bai CX
Acta Pharmacol Sin; 2012 May; 33(5):675-81. PubMed ID: 22447226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
